HomeINMB • NASDAQ
add
INmune Bio Inc
Previous close
$4.89
Day range
$4.86 - $5.05
Year range
$4.47 - $14.74
Market cap
108.42M USD
Avg Volume
226.21K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 12.29M | 43.34% |
Net income | -12.09M | -41.22% |
Net profit margin | — | — |
Earnings per share | -0.60 | -25.00% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 33.55M | -19.76% |
Total assets | 52.78M | -15.82% |
Total liabilities | 14.11M | -21.48% |
Total equity | 38.68M | — |
Shares outstanding | 22.17M | — |
Price to book | 2.81 | — |
Return on assets | -58.37% | — |
Return on capital | -73.04% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -12.09M | -41.22% |
Cash from operations | -6.99M | -63.84% |
Cash from investing | — | — |
Cash from financing | 9.79M | 667.65% |
Net change in cash | 2.48M | 141.30% |
Free cash flow | -2.66M | -81.82% |
About
Founded
2015
Headquarters
Website
Employees
14
